Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-01

Clinical Trial Update: Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot) [Phase 3]

View source ↗

Summary

Phase 3 trial update on azithromycin for uncomplicated severe acute malnutrition in Burkina Faso, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Uncomplicated Severe Acute Malnutrition | Phase 3 | Status: COMPLETED | Results posted: 2022-09-01